Randomized clinical trial comparing the effect of different homeostatic agents for controlling homeostasis after hepatic resection.

Phase 2

• Conditions: Condition 1: Liver metastasis. Condition 2: Malignant neoplasm of liver and intrahepatic bile ducts. Condition 3: Topical homeostatic agents. Condition 4: Other diseases of liver in need of surgery.; Secondary malignant neoplasm of liver and intrahepatic bile duct; Malignant neoplasm of liver and intrahepatic bile ducts; Topical agent, unspecified; Other specified diseases of liver

• Registration Number: IRCT2013031712834N1
• Lead Sponsor: Vice chancellor for research, Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 45

Inclusion Criteria

Age between 18-75 years old; all patients undergoing hepatic resection and have oozing after resection; patients with no coagulation disorders
Exclusion criteria: Death during the surgery;hepatic mass to be none resectable; early closure of the surgery; hepatic insufficiency after surgery; coagulopathy after the surgery; patients with need for re-surgery due to bleeding or bile leakage other than resection site; patients with chronic hepatic disease

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Bleeding control. Timepoint: Every 6 hours until 48 hours. Method of measurement: Observation during surgery and evaluation of Hb, INR every 6 hours.

Secondary Outcome Measures

Name	Time	Method
Complications after oozing control. Timepoint: Days 1, 3, 5,7 after surgery. Method of measurement: Physical examination and paraclinical evaluations.